• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际严重哮喘登记研究(ISAR)的发展:一项改良 Delphi 研究。

Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study.

机构信息

Optimum Patient Care, Cambridge, UK.

UK Severe Asthma Network and National Registry, Queen's University Belfast, Belfast, Northern Ireland, UK.

出版信息

J Allergy Clin Immunol Pract. 2019 Feb;7(2):578-588.e2. doi: 10.1016/j.jaip.2018.08.016. Epub 2018 Sep 1.

DOI:10.1016/j.jaip.2018.08.016
PMID:
30179741
Abstract

BACKGROUND

The lack of centralized data on severe asthma has resulted in a scarcity of information about the disease and its management. The development of a common data collection tool for the International Severe Asthma Registry (ISAR) will enable standardized data collection, subsequently enabling data interoperability.

OBJECTIVES

To create a standardized list of variables for the first international registry for severe asthma via expert consensus.

METHODS

A modified Delphi process was used to reach consensus on a minimum set of variables to capture in ISAR: the core variables. The Delphi panel brought together 27 international experts in the field of severe asthma research. The process consisted of 3 iterative rounds. In each round, all Delphi panel members were issued an electronic ISAR Delphi workbook to complete and return to the ISAR Delphi administrator. Workbooks and result summaries were anonymously distributed by the Delphi administrator to all panel members at subsequent rounds. Finalization of the core variable list was facilitated by 2 face-to-face meetings.

RESULTS

Of the initial 747 selected variables, the Delphi panel reached a consensus on 95. The chosen variables will allow severe asthma to be assessed against patient demographics and medical history, patient-reported outcomes, diagnostic information, and clinical characteristics. Physician-reported outcomes such as nonadherence and information about treatment and management strategies will also be recorded.

CONCLUSIONS

This is the first global attempt to generate an ISAR using a common set of core variables to ensure that data collected across all participating countries are standardized.

摘要

背景

缺乏关于严重哮喘的集中数据导致了对该疾病及其管理的信息匮乏。国际严重哮喘登记处(ISAR)通用数据收集工具的开发将实现标准化的数据收集,从而实现数据互操作性。

目的

通过专家共识,为首个国际严重哮喘登记处创建标准化变量清单。

方法

采用改良 Delphi 流程就 ISAR 中应纳入的变量达成共识:核心变量。Delphi 小组汇集了 27 名严重哮喘研究领域的国际专家。该流程包括 3 轮迭代。在每一轮中,所有 Delphi 小组成员都会收到一份电子 ISAR Delphi 工作簿,以完成并返回给 ISAR Delphi 管理员。随后的轮次中,Delphi 管理员会以匿名方式将工作簿和结果摘要分发给所有小组成员。通过 2 次面对面会议促进了核心变量列表的最终确定。

结果

在最初的 747 个选定变量中,Delphi 小组就 95 个变量达成共识。所选变量将允许根据患者人口统计学和病史、患者报告的结果、诊断信息和临床特征对严重哮喘进行评估。还将记录医生报告的结果,如不遵医嘱以及有关治疗和管理策略的信息。

结论

这是首次尝试使用通用核心变量集生成 ISAR,以确保收集的所有参与国家的数据标准化。

相似文献

1
Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study.国际严重哮喘登记研究(ISAR)的发展:一项改良 Delphi 研究。
J Allergy Clin Immunol Pract. 2019 Feb;7(2):578-588.e2. doi: 10.1016/j.jaip.2018.08.016. Epub 2018 Sep 1.
2
Adult Severe Asthma Registries: A Global and Growing Inventory.成人重度哮喘登记处:一份全球且不断增长的清单。
Pragmat Obs Res. 2023 Oct 20;14:127-147. doi: 10.2147/POR.S399879. eCollection 2023.
3
International severe asthma registry (ISAR): protocol for a global registry.国际严重哮喘登记研究(ISAR):全球登记研究方案。
BMC Med Res Methodol. 2020 Aug 14;20(1):212. doi: 10.1186/s12874-020-01065-0.
4
Editor's Choice - Recommendations for Registry Data Collection for Revascularisations of Acute Limb Ischaemia: A Delphi Consensus from the International Consortium of Vascular Registries.编辑精选 - 急性肢体缺血血运重建注册数据采集建议:国际血管登记研究联合会的德尔菲共识。
Eur J Vasc Endovasc Surg. 2019 Jun;57(6):816-821. doi: 10.1016/j.ejvs.2019.02.023. Epub 2019 May 22.
5
International Consortium of Vascular Registries Consensus Recommendations for Peripheral Revascularisation Registry Data Collection.国际血管登记研究联合会关于周围血管重建术登记研究数据采集的共识推荐意见。
Eur J Vasc Endovasc Surg. 2018 Aug;56(2):217-237. doi: 10.1016/j.ejvs.2018.04.006. Epub 2018 May 30.
6
International Severe Asthma Registry: Mission Statement.国际严重哮喘登记处:使命宣言。
Chest. 2020 Apr;157(4):805-814. doi: 10.1016/j.chest.2019.10.051. Epub 2019 Dec 12.
7
A Delphi Consensus on Patient Reported Outcomes for Registries and Trials Including Patients with Intermittent Claudication: Recommendations and Reporting Standard.基于间歇性跛行患者的注册研究和临床试验中患者报告结局的德尔菲共识:推荐意见和报告标准。
Eur J Vasc Endovasc Surg. 2022 Nov;64(5):526-533. doi: 10.1016/j.ejvs.2022.08.011. Epub 2022 Aug 17.
8
Primary Care Severe Asthma Registry and Education Project (PCSAR-EDU): Phase 1 - an e-Delphi for registry definitions and indices of clinician behaviour.初级保健严重哮喘登记和教育项目(PCSAR-EDU):第 1 阶段 - 电子德尔菲法用于登记定义和临床医生行为指标。
BMJ Open. 2022 Mar 24;12(3):e055958. doi: 10.1136/bmjopen-2021-055958.
9
Development of the Advancing the Patient Experience in COPD Registry: A Modified Delphi Study.慢性阻塞性肺疾病(COPD)登记中提升患者体验的发展:一项改良德尔菲研究
Chronic Obstr Pulm Dis. 2021 Jan;8(1):135-51. doi: 10.15326/jcopdf.2020.0154.
10
Establishing an expert consensus for the operational definitions of asthma-associated infectious and inflammatory multimorbidities for computational algorithms through a modified Delphi technique.通过改良的德尔菲技术,为计算算法中哮喘相关感染性和炎症性共病的操作定义建立专家共识。
BMC Med Inform Decis Mak. 2021 Nov 8;21(1):310. doi: 10.1186/s12911-021-01663-y.

引用本文的文献

1
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress Update.国际重症哮喘注册研究(ISAR):2017 - 2024年现状与进展更新
Tuberc Respir Dis (Seoul). 2025 Apr;88(2):193-215. doi: 10.4046/trd.2024.0198. Epub 2025 Feb 6.
2
Improving the Transparency and Replicability of Consensus Methods: Respiratory Medicine as a Case Example.提高共识方法的透明度和可重复性:以呼吸医学为例
Pragmat Obs Res. 2024 Oct 15;15:201-207. doi: 10.2147/POR.S478163. eCollection 2024.
3
Impact of comorbidities on EQ-5D quality-of-life index in severe asthma.
合并症对重度哮喘患者EQ-5D生活质量指数的影响。
J Allergy Clin Immunol Glob. 2024 May 31;3(3):100286. doi: 10.1016/j.jacig.2024.100286. eCollection 2024 Aug.
4
Application of the Delphi method to the development of common data elements for social drivers of health: A systematic scoping review.德尔菲法在社会健康驱动因素通用数据元素开发中的应用:系统范围界定综述。
Transl Behav Med. 2024 Jun 27;14(7):426-433. doi: 10.1093/tbm/ibae020.
5
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults.探索成人接受生物治疗后重度哮喘临床缓解的定义和预测因素。
Am J Respir Crit Care Med. 2024 Oct 1;210(7):869-880. doi: 10.1164/rccm.202311-2192OC.
6
Adult Severe Asthma Registries: A Global and Growing Inventory.成人重度哮喘登记处:一份全球且不断增长的清单。
Pragmat Obs Res. 2023 Oct 20;14:127-147. doi: 10.2147/POR.S399879. eCollection 2023.
7
The Contact Dermatitis Quality of Life Index (CDQL): Survey Development and Content Validity Assessment.接触性皮炎生活质量指数(CDQL):调查开发与内容效度评估。
JMIR Dermatol. 2021 Dec 16;4(2):e30620. doi: 10.2196/30620.
8
Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study).德国哮喘网络严重哮喘登记处使用美泊利单抗的真实世界经验(MepoGAN研究)。
J Asthma Allergy. 2023 May 11;16:541-552. doi: 10.2147/JAA.S403286. eCollection 2023.
9
Primary care asthma surveillance: a review of knowledge translation tools and strategies for quality improvement.基层医疗中的哮喘监测:知识转化工具与质量改进策略综述
Allergy Asthma Clin Immunol. 2023 Jan 17;19(1):3. doi: 10.1186/s13223-022-00755-2.
10
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy.国际重症哮喘登记中高剂量类固醇暴露且已启动或未启动生物治疗患者的特征分析。
J Asthma Allergy. 2022 Oct 21;15:1491-1510. doi: 10.2147/JAA.S377174. eCollection 2022.